Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Expansion Outlook: $24.11 Billion by 2029 Forecast
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market From 2025 To 2034?
The ribose-nucleic acid (rna)-based therapeutics market has experienced robust expansion in recent years. Projections indicate its value will increase from $15.79 billion in 2024 to $17.22 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. Historical growth in this sector is largely due to factors such as increased investment and funding, the groundbreaking discovery of RNA interference (RNAi), successful clinical outcomes for antisense oligonucleotides (ASOs), supportive regulatory environments and frameworks, and strategic collaborations and partnerships.
The ribose-nucleic acid (rna)-based therapeutics market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $24.11 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.8%. This growth can be attributed to several factors, including the broadening of therapeutic indications, increasing market demand and adoption, supportive regulatory environments, the integration of AI and machine learning, and new applications in rare diseases. Within this period, major trends are expected to include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, further regulatory advancements, and continued commercialization and market growth.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
Which Drivers Are Supporting Growth Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The expanding occurrence of cancer is projected to fuel the advancement of the ribose-nucleic acid (RNA)-based therapeutics market in the future. Cancer is defined as a disease characterized by the unchecked proliferation and dissemination of abnormal cells, which could prove fatal without intervention. The widespread presence of cancer stems from factors such as an aging demographic, shifts in lifestyle, heightened exposure to hazards, and improved diagnostic techniques. RNA-based therapeutics present a promising approach for combating cancer by directly addressing its underlying genetic and molecular pathways. For example, data from August 2023, published by the Australian Institute of Health and Welfare, an Australia-based government administration for health, indicated that approximately 151,000 people received a cancer diagnosis (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021, a number anticipated to grow to 185,000 by 2030. Consequently, the rising incidence of cancer is propelling the ribose-nucleic acid (RNA)-based therapeutics market.
What Are The Major Segments Identified In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The ribose-nucleic acid (rna)-based therapeuticsmarket covered in this report is segmented –
1) By Type: RNA Interference (RNAi); RNA Antisense
2) By Technology: Enabling Technology; Enabled Technology
3) By Therapeutic Area: Oncology; Genetic Disorder; Ophthalmology; Hematological Disorders; Acute Hepatic Porphyria (AHP); Other Therapeutic Areas
4) By End User: Research Institutes; Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA); MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs); Antisense RNA
What Trends Are Redefining The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Dynamics?
Leading firms within the ribose nucleic acid (RNA)-based therapeutics market are concentrating on creating novel drug therapies, including messenger RNA (mRNA)-based booster vaccines. Their aim is to boost immunization efficacy, combat new viral strains, and extend the lasting protection provided by vaccines. These mRNA-based booster vaccines function by employing messenger RNA to instruct cells to produce a specific protein, which subsequently strengthens the body’s immune defense against a given pathogen. As an illustration, in June 2023, Gennova Biopharmaceuticals Ltd., an Indian pharmaceutical enterprise, introduced GEMCOVAC-OM. This marked India’s initial mRNA booster vaccine designed specifically for the COVID-19 Omicron variant. The necessity of this booster arises from the reduced effectiveness of earlier vaccines when confronting the Omicron variant. By leveraging mRNA technology, GEMCOVAC-OM strengthens immunity and delivers superior protection against the continually changing virus.
Which Leading Companies Dominate The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Share?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Download The Full Report For Exclusive Market Findings:
What Regional Growth Trends Are Shaping The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Outlook?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Browse Through More Reports Similar to the Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market 2025, By The Business Research Company
Isothermal Nucleic Acid Amplification Technology Global Market Report 2025
Nucleic Acid Based Gene Therapy Global Market Report 2025
Nucleic Acid Isolation And Purification Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
